A risk-adapted approach to reTURBT in high-grade T1 NMIBC

Bladder Cancer · Published 2026-05-05 · DOI 10.1177/23523735261449093

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1177/23523735261449093

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Radiogenomic analysis of muscle-invasive bladder cancer using CT-based texture analysis · Bladder Cancer · 2026 · Same journal
• The Evolution of Nadofaragene Firadenovec: A Review and the Path Forward · Bladder Cancer · 2024 · Same journal
• Organoid models in bladder cancer: From bench to bedside? · Bladder Cancer · 2025 · Same journal
• Induction and characterization of neoplastic bladder tumors in a transgenic porcine model · Bladder Cancer · 2026 · Same journal
• Single-cell RNA sequencing and spatial transcriptome analysis in bladder cancer: Current status and future perspectives · Bladder Cancer · 2025 · Same journal
• Clinical trials corner issue 12(1) · Bladder Cancer · 2026 · Same journal
• Effect of Bacille Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer After Prostate Radiotherapy · Bladder Cancer · 2024 · Same journal
• Dysregulation of mRNA splicing in urothelial carcinoma: Clinical, diagnostic and therapeutic implications · Bladder Cancer · 2025 · Same journal
• Factors Influencing Patient Decision-Making in the Treatment of Muscle-Invasive Bladder Cancer · Bladder Cancer · 2024 · Same journal
• Association of CCL2/CCR2 gene polymorphisms and bladder cancer risk in a hispanic-rich US population · Bladder Cancer · 2026 · Same journal